PulseAugur
EN
LIVE 17:13:04

ToolMol framework enhances drug discovery with LLM and genetic algorithms

Researchers have developed ToolMol, an evolutionary agentic framework designed to improve drug discovery using large language models. This framework combines a genetic algorithm with an LLM operator that iteratively refines potential drug candidates. ToolMol utilizes a toolbox of RDKit-backed functions for precise molecular modifications, achieving state-of-the-art results in binding affinity and Absolute Binding Free Energy scores, outperforming existing methods. AI

IMPACT This framework could accelerate the discovery of new drugs by improving the efficiency and quality of LLM-driven molecular generation.

RANK_REASON Publication of a new research paper detailing a novel framework for drug discovery. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.NE (Neural & Evolutionary) →

AI-generated summary · Google Gemini · from 3 sources. How we write summaries →

COVERAGE [3]

  1. arXiv cs.AI TIER_1 English(EN) · Xiaoyu Xiong, Yuqi Ren, Deyi Xiong ·

    EvoSci: A Bio-Inspired Multi-Agent Framework for the Evolution of Scientific Discovery

    arXiv:2605.24018v1 Announce Type: new Abstract: Large language models (LLMs), have shown strong potential in scientific discovery, yet existing methods still face substantial challenges in the design of research workflows and multi-role collaboration mechanisms. To mitigate these…

  2. arXiv cs.MA (Multiagent) TIER_1 English(EN) · Deyi Xiong ·

    EvoSci: A Bio-Inspired Multi-Agent Framework for the Evolution of Scientific Discovery

    Large language models (LLMs), have shown strong potential in scientific discovery, yet existing methods still face substantial challenges in the design of research workflows and multi-role collaboration mechanisms. To mitigate these issues, we propose EvoSci, a multi-agent scient…

  3. arXiv cs.NE (Neural & Evolutionary) TIER_1 English(EN) · Rose Yu ·

    ToolMol: Evolutionary Agentic Framework for Multi-objective Drug Discovery

    Advances in large language models (LLMs) have recently opened new and promising avenues for small-molecule drug discovery. Yet existing LLM-based approaches for molecular generation often suffer from high rates of invalid and low-quality ligand candidates, a result of the syntact…